There are numerous reported cases of extended spectrum beta lactamases (ESBLs) producing Enterobacteriaceae in Nigeria, with little effort done on the molecular detection. Epidemiological studies around the world have investigated the prevalence of ESBL-producing enterobacteriaceae and they have seen multiple mechanisms of drug-resistance. Our study was designed to detect ESBLs genes such as CTX-M, SHV, and TEM using PCR from clinical isolates in a tertiary hospital in Sokoto metropolis. Clinical isolates from the Microbiology laboratory of the tertiary hospital was collected for 3 months. These isolates were identified using standard microbiological methods. They were tested against 8 antibiotics using the modified Kirby Bauer disc diffusion method. Multidrug resistant isolates were screened for ESBL production, and further confirmed by the Double Disc Synergy Test (DDST). Genotypic confirmation was carried out using multiplex Polymerase Chain Reaction (PCR). A total of 47 isolates made up of 21 E. coli (44.6%), 13 Klebsiella spp (27.6%), 7 Salmonella spp (14.9%), 5 Proteus mirabilis (10.6%), and 1 Enterobacter spp (2.1%) were obtained from urine, stool, and wound swab. Out of the 47 isolates, (45) 95.7% were multidrug resistant. Twenty-five (53.2%) were potential ESBL producers, while only 5 (20.0%) were confirmed phenotypically using a DDST. PCR results revealed 4 out of 5 of the isolates were possessing ESBL genes. It also revealed that 3 isolates co-produce TEM and SHV at 403bp and 293bp respectively. Only 1 isolate produced CTX-M gene at 569bp. The prevalence of ESBL production in the Gram negative enterobacteriaceae in our study did not indicate a high prevalence as reported by some studies in Sokoto and Northwest Nigeria.
Polymerase chain reaction (PCR) is a valuable technique in the diagnosis of bacterial infection. Molecular methods might be superior to bacterial culture in providing the etiologic diagnosis (Morgenstern et al., 2018) . Another advantage of bacterial PCR is connected to its broad-range nature since rare or unexpected pathogen can be found. A comparison to culture results reveals difficulties in detecting gram positive species and Mycobacterium by PCR (Mirsaeidi et al., 2014) . Production of ESBLs is one of the most prevalent resistance mechanisms in Gram-negative bacilli. Initially, ESBLs were predominantly described in K. pneumoniae and E. coli strains, but recently the enzymes were found in other genera of the Enterobacteriaceae family . Extended Spectrum Beta Lactamases (ESBLs) in human medicine first came to prominence following the introduction of the extended-spectrum cephalosporins (Rebbah et al., 2018) . In the 1980's, the term was applied to mutants of the already common plasmid mediated β-lactamases such as SHV and TEM. One of the first detected, which originated in France, was TEM-3 ESBL which had been presumed to have been selected in the human host following the introduction and use of cefotaxine. Both of the 'parent' genotypes of this β-lactamase genes blaTEM-1 blaTEM-2 were widely disseminated amongst medically important members of Enterobacteriaceae and Acinetobacter spp. and it seemed logical (Mendonça, 2009 ). The extended spectrum form of the β-lactamase would become much more widely disseminated throughout the world under the selective pressure of the use of third generation cephalosporins (Ahlstrom et al., 2018) . This happened to a degree in that particularly some variants of TEM, such as TEM-10, TEM-24 and SHV-12, became widely distributed, particularly amongst Klebsiella .spp. in hospital settings, but never reached high levels of prevalence (usually <20%). There also was never a significant spread of these genes into the more general UNGO-KORE, HY; BULUS, MW; NUHU, T; OLOWOOKERE, A; SAADATU, MJ; ALHASAN, MA; IBRAHIM, AO; SHUAIBU, AS environmental and commensally pool of Enterobacteriaceae, even in countries where ESBL is predominant (Iredell et al., 2016) .
Phenotype rates were reported to be very high, such as in China and India. The initially named MEN-1 ESBL from an E. coli isolate characterized in France from a patient in Italy (1990) was found to be identical to CTX-M-1 from an E.coli isolated from a child in Germany (1989) (Hawkey, 2017) . The objective of this paper is the genotypic detection of extended spectrum beta lactamases from selected bacterial isolates obtained from Specialist Hospital Sokoto, Nigeria.
MATERIALS AND METHODS
Sample Collection: The isolates were obtained from the Microbiology laboratory in the Specialist Hospital Sokoto and were taken to the department of Pharmaceutics and Pharmaceutical Microbiology Laboratory Usmanu Danfodiyo University Sokoto for further analysis.
Preliminary Test for ESBL Production: The isolates were screened for ESBL production using cefotaxime (30µg) and the ceftazidime (30µg) discs as described by CLSI (2015).
Confirmatory
Test for ESBL Production: Confirmation of ESBL phenotype was performed for 47 clinical samples obtained from blood, urine, stool, and saliva by Double Disc Synergy Test (DDST) using antibiotic discs containing two 3 rd generation Cephalosporin (CTZ, 30ug and CTX, 30ug) and Augumentin(AMC, 30ug). Using a sterile needle, CTZ and CTX were placed at a distance of 20mm center to center from AMC on Mueller Hinton Agar. The plates were then incubated at 37 0 c for 24 hours after which they were examined for an extension of the edge of zone of inhibition of antibiotic disc towards the AMC. Enhancement of zone of inhibition of either or both the CTZ and CTX towards the AMC disc is indicative of ESBL production (EUCAST, 2014)
Genotypic detection of ESBL: Isolates preparation:
The materials used in the preparation was sterilized using the autoclave, then the peptone water was prepared by weighing 1.275g of solid peptone which was dissolved in 50mls distilled water inside a beaker of 100ml capacity by stirring on a water bath until it completely dissolved. Then it was cover with an aluminum foil and was sterilized in the autoclave at 121 o C for 15mins. Then 5mls sterile syringe was used to aseptically transfer 5mls of the peptone water into five different test tubes and covered. Then the inoculums which were stored in the refrigerator was aseptically transferred into each of the test tubes already labeled with sample 1-5 where 1,3 and 5 are Klebsiellas, 2 is Proteus mirabilis, and 4 is E. coli. Then they were incubated at 37 o C for 24hrs.
DNA Extraction: An overnight suspension of the test bacteria was prepared by transferring a loop full of the isolates into a test tube containing 2mls of peptone water. The suspension was centrifuged at 6000rpm for 5 minutes then, the supernatant was discarded and the sediments (cells) were transferred into a 1.5mls microfuge tube. Then, the cells were re suspended in a 50µl of nuclease free water and the tubes were transferred into a water bath and boiled at 95 o C for 30 minutes. Then the tubes were allowed to cool and were centrifuged at 13000rpm for 5 minutes at 4 o C,then the supernatants were transferred to a nuclease free 0.5ml microfuge tubes and the extracted DNA were stored at -20 o C until when required for the PCR (Central Research Laboratory , 2018).
Multiplex PCR of ESBL:
A total of 25µl PCR reaction mix containing 5µl of the DNA template was used. 12.5µl of Biorad mixer, 4.5µlof nuclease free water and 0.5µl each of the following primers were multiplexed The PCR primers were transferred to a Biorad 9700 thermocycler and subjected to initial denaturation at 94 o C for 3 minutes. The PCR was carried using the procedure below (Vincent et al., 2018) Agarose Gel Electrophoresis: After ensuring that the electronic digital balance was calibrated, 1.5g of Agarose powder was weighed and dissolved in 100ml of distilled water and was transferred into the water bath for complete dissolution. Then the molten agar was allowed to cool to about 50 o C and 5µl of ethidium bromide was added and swirled to mix. The gel was poured into a wide Biorad gel casting unit, and was allowed for 30minutes to solidify and transferred into an agarose gel tank and was flooded with 500mls of 0.5x TBE buffer. Then 10µl of the standard was mixed with a 6x loading dye and loaded in each allocated wells. The tank was closed and the electrophoresis power pack was programmed to run at 10volts for 30min. then the gel outcome was viewed using Biorad gel imager. The result was obtained with reference to the base pairs of both forward and reverse base pairs (Westermeier, 2016) .
RESULTS AND DISCUSSION ESBL Percentage Distribution:
The result in fig1 shows that out of the 47 isolates collected, only 5 were confirmed to produce ESBL, showing a prevalence of 11% in the Specialist Hospital Sokoto. The highest prevalence was found in Klebsiella spp (3 out of 5) followed by Proteus mirabilis (1 out of 5), and E. coli (1 out of 5).
Percentage Distribution of ESBL and Non ESBL Producers
From the result obtained in fig 2, 80% of the processed samples were found to be positive for ESBL which was in line with to Nuhu et al., 2016 were negative which signifies that majority of the population sampled were free from the ESBL production but a total clearance is expected because the 11% can spread over time to the rest of the population. From the multiplexed PCR results obtained in fig2 the different amplicon size of 293bp for SHV-F (CGCCTGTGTATTATCTCCCT), SHVR(CGAGTAGTCCACCAGATCCT), 403bp for TEM-F(TTTCGTGTCGCCCTTATTCC), and 569bp for CTX-M primers for both forward and reverse Oligonucleotides was observed that sample 1,2 and 3 have two bands of amplicons of 293bp and 403bp which signifies that the primers that amplified the gene for ESBL were SHV and TEM respectively while sample 4 has only one band of 569bp which shows that it was amplified by CTX-M primer and sample 5 has no band signifying that there is no gene coding for ESBL or the specific primer that can amplify the gene was not used for the experiment, but 80% of the isolates where ESBL producers, while 20% of the sample which was just 1 was found to be non ESBL producer.
Conclusion:
The prevalence of ESBLs in the hospital samples collected was 11% and there is a high risk of it rising to a higher percentage due to the fact that patient and health workers could be a medium of transferring some of this resistant organism. The percentage of the detected ESBL producers was 80% which means that the phenotypic methods of identification could be reliable.
